Proteomic identification of urinary biomarkers of diabetic nephropathy

Paturi V. Rao, Xinfang Lu, Melissa Standley, Patrick Pattee, Gundupalle Neelima, Gudige Girisesh, K. V. Dakshinamurthy, Charles Roberts, Srinivasa R. Nagalla

    Research output: Contribution to journalArticle

    128 Citations (Scopus)

    Abstract

    OBJECTIVE - Diabetic nephropathy is a serious complication of both type 1 and type 2 diabetes, and, unless arrested, leads to end-stage renal disease. Current diagnosis consists of urine assays of microalbuminuria, which have inadequate specificity and sensitivity. RESEARCH DESIGN AND METHODS - We used proteomic analyses to identify novel biomarkers of nephropathy in urine from type 2 diabetic patients with demonstrated normo-, micro-, or macroalbuminuria. Samples were analyzed by fluorescence two-dimensional (2-D) differential in-gel electrophoresis (DIGE), and protein identification was performed by liquid chromatography-tandem mass spectrometry. RESULTS - 2-D DIGE analysis of the urinary proteome in diabetes with nephropathy identified 195 protein spots representing 62 unique proteins. These proteins belonged to several functional groups, i.e., cell development, cell organization, defense response, metabolism, and signal transduction. Comparisons between control and diabetic subjects with different stages of renal dysfunction revealed the differential expression of several proteins. Spot volume quantification identified 7 proteins that were progressively upregulated with increasing albuminuria and 4 proteins that exhibited progressive downregulation. The majority of these potential candidate biomarkers were glycoproteins. CONCLUSIONS - These data demonstrate the ability of proteomic analyses to reveal potential biomarkers for diabetic nephropathy in urine, an important step forward in advancing accurate diagnosis and our understanding of disease mechanisms.

    Original languageEnglish (US)
    Pages (from-to)629-637
    Number of pages9
    JournalDiabetes Care
    Volume30
    Issue number3
    DOIs
    StatePublished - Mar 2007

    Fingerprint

    Diabetic Nephropathies
    Proteomics
    Biomarkers
    Proteins
    Urine
    Electrophoresis
    Gels
    Albuminuria
    Proteome
    Tandem Mass Spectrometry
    Type 1 Diabetes Mellitus
    Liquid Chromatography
    Type 2 Diabetes Mellitus
    Chronic Kidney Failure
    Signal Transduction
    Glycoproteins
    Research Design
    Down-Regulation
    Fluorescence
    Kidney

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Rao, P. V., Lu, X., Standley, M., Pattee, P., Neelima, G., Girisesh, G., ... Nagalla, S. R. (2007). Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care, 30(3), 629-637. https://doi.org/10.2337/dc06-2056

    Proteomic identification of urinary biomarkers of diabetic nephropathy. / Rao, Paturi V.; Lu, Xinfang; Standley, Melissa; Pattee, Patrick; Neelima, Gundupalle; Girisesh, Gudige; Dakshinamurthy, K. V.; Roberts, Charles; Nagalla, Srinivasa R.

    In: Diabetes Care, Vol. 30, No. 3, 03.2007, p. 629-637.

    Research output: Contribution to journalArticle

    Rao, PV, Lu, X, Standley, M, Pattee, P, Neelima, G, Girisesh, G, Dakshinamurthy, KV, Roberts, C & Nagalla, SR 2007, 'Proteomic identification of urinary biomarkers of diabetic nephropathy', Diabetes Care, vol. 30, no. 3, pp. 629-637. https://doi.org/10.2337/dc06-2056
    Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care. 2007 Mar;30(3):629-637. https://doi.org/10.2337/dc06-2056
    Rao, Paturi V. ; Lu, Xinfang ; Standley, Melissa ; Pattee, Patrick ; Neelima, Gundupalle ; Girisesh, Gudige ; Dakshinamurthy, K. V. ; Roberts, Charles ; Nagalla, Srinivasa R. / Proteomic identification of urinary biomarkers of diabetic nephropathy. In: Diabetes Care. 2007 ; Vol. 30, No. 3. pp. 629-637.
    @article{d9ab0bba46de42728cfca490a0c166f3,
    title = "Proteomic identification of urinary biomarkers of diabetic nephropathy",
    abstract = "OBJECTIVE - Diabetic nephropathy is a serious complication of both type 1 and type 2 diabetes, and, unless arrested, leads to end-stage renal disease. Current diagnosis consists of urine assays of microalbuminuria, which have inadequate specificity and sensitivity. RESEARCH DESIGN AND METHODS - We used proteomic analyses to identify novel biomarkers of nephropathy in urine from type 2 diabetic patients with demonstrated normo-, micro-, or macroalbuminuria. Samples were analyzed by fluorescence two-dimensional (2-D) differential in-gel electrophoresis (DIGE), and protein identification was performed by liquid chromatography-tandem mass spectrometry. RESULTS - 2-D DIGE analysis of the urinary proteome in diabetes with nephropathy identified 195 protein spots representing 62 unique proteins. These proteins belonged to several functional groups, i.e., cell development, cell organization, defense response, metabolism, and signal transduction. Comparisons between control and diabetic subjects with different stages of renal dysfunction revealed the differential expression of several proteins. Spot volume quantification identified 7 proteins that were progressively upregulated with increasing albuminuria and 4 proteins that exhibited progressive downregulation. The majority of these potential candidate biomarkers were glycoproteins. CONCLUSIONS - These data demonstrate the ability of proteomic analyses to reveal potential biomarkers for diabetic nephropathy in urine, an important step forward in advancing accurate diagnosis and our understanding of disease mechanisms.",
    author = "Rao, {Paturi V.} and Xinfang Lu and Melissa Standley and Patrick Pattee and Gundupalle Neelima and Gudige Girisesh and Dakshinamurthy, {K. V.} and Charles Roberts and Nagalla, {Srinivasa R.}",
    year = "2007",
    month = "3",
    doi = "10.2337/dc06-2056",
    language = "English (US)",
    volume = "30",
    pages = "629--637",
    journal = "Diabetes Care",
    issn = "1935-5548",
    publisher = "American Diabetes Association Inc.",
    number = "3",

    }

    TY - JOUR

    T1 - Proteomic identification of urinary biomarkers of diabetic nephropathy

    AU - Rao, Paturi V.

    AU - Lu, Xinfang

    AU - Standley, Melissa

    AU - Pattee, Patrick

    AU - Neelima, Gundupalle

    AU - Girisesh, Gudige

    AU - Dakshinamurthy, K. V.

    AU - Roberts, Charles

    AU - Nagalla, Srinivasa R.

    PY - 2007/3

    Y1 - 2007/3

    N2 - OBJECTIVE - Diabetic nephropathy is a serious complication of both type 1 and type 2 diabetes, and, unless arrested, leads to end-stage renal disease. Current diagnosis consists of urine assays of microalbuminuria, which have inadequate specificity and sensitivity. RESEARCH DESIGN AND METHODS - We used proteomic analyses to identify novel biomarkers of nephropathy in urine from type 2 diabetic patients with demonstrated normo-, micro-, or macroalbuminuria. Samples were analyzed by fluorescence two-dimensional (2-D) differential in-gel electrophoresis (DIGE), and protein identification was performed by liquid chromatography-tandem mass spectrometry. RESULTS - 2-D DIGE analysis of the urinary proteome in diabetes with nephropathy identified 195 protein spots representing 62 unique proteins. These proteins belonged to several functional groups, i.e., cell development, cell organization, defense response, metabolism, and signal transduction. Comparisons between control and diabetic subjects with different stages of renal dysfunction revealed the differential expression of several proteins. Spot volume quantification identified 7 proteins that were progressively upregulated with increasing albuminuria and 4 proteins that exhibited progressive downregulation. The majority of these potential candidate biomarkers were glycoproteins. CONCLUSIONS - These data demonstrate the ability of proteomic analyses to reveal potential biomarkers for diabetic nephropathy in urine, an important step forward in advancing accurate diagnosis and our understanding of disease mechanisms.

    AB - OBJECTIVE - Diabetic nephropathy is a serious complication of both type 1 and type 2 diabetes, and, unless arrested, leads to end-stage renal disease. Current diagnosis consists of urine assays of microalbuminuria, which have inadequate specificity and sensitivity. RESEARCH DESIGN AND METHODS - We used proteomic analyses to identify novel biomarkers of nephropathy in urine from type 2 diabetic patients with demonstrated normo-, micro-, or macroalbuminuria. Samples were analyzed by fluorescence two-dimensional (2-D) differential in-gel electrophoresis (DIGE), and protein identification was performed by liquid chromatography-tandem mass spectrometry. RESULTS - 2-D DIGE analysis of the urinary proteome in diabetes with nephropathy identified 195 protein spots representing 62 unique proteins. These proteins belonged to several functional groups, i.e., cell development, cell organization, defense response, metabolism, and signal transduction. Comparisons between control and diabetic subjects with different stages of renal dysfunction revealed the differential expression of several proteins. Spot volume quantification identified 7 proteins that were progressively upregulated with increasing albuminuria and 4 proteins that exhibited progressive downregulation. The majority of these potential candidate biomarkers were glycoproteins. CONCLUSIONS - These data demonstrate the ability of proteomic analyses to reveal potential biomarkers for diabetic nephropathy in urine, an important step forward in advancing accurate diagnosis and our understanding of disease mechanisms.

    UR - http://www.scopus.com/inward/record.url?scp=33847691204&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33847691204&partnerID=8YFLogxK

    U2 - 10.2337/dc06-2056

    DO - 10.2337/dc06-2056

    M3 - Article

    C2 - 17327332

    AN - SCOPUS:33847691204

    VL - 30

    SP - 629

    EP - 637

    JO - Diabetes Care

    JF - Diabetes Care

    SN - 1935-5548

    IS - 3

    ER -